Meeing

Dr. Kun-Po Li, BD Director of T-E Meds, an is set to captivate the audience at The BiG ADC/XDC Conference […]

We’re thrilled to announce that Dr. Hsing-Mao Chu, CEO of T-E Meds is honored to present at The 5th ADC

Our Chairman, Dr. Tse-Wen Chang and VP of R&D, Dr. Hsing-Mao Chu are honored speakers at the prestigious J.P. Morgan

Dr. Hsing-Mao Chu, CEO at T-E Meds, will be presenting at the prestigious World ADC conference in San Diego on October

Immunwork is thrilled to announce its participation in the upcoming BIO Asia-Taiwan conference. Join us on July 28th as Dr. Kun-Po

T-E Meds has been selected as a finalist for the Start-up Stadium picking competition in the BIO international convention.  T-E

Dr. Hsing-Mao Chu, VP of R&D at Immunwork is speaking at the 2nd Next-Generation Conjugates Summit in Boston next week. Dr.

Immunwork, Inc., today announced that it is presenting at Biotech Showcase™ 2023. This year, registered attendees can view Immunwork’s presentation

Reported link: https://news.gbimonthly.com/tw/article/show.php?num=54517&kind=1